Molecular Formula | C17H14O3 |
Molar Mass | 266.29 |
Solubility | DMSO: soluble15mg/mL (clear solution) |
Appearance | powder |
Color | white to beige |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
In vitro study | When L1210 cells are exposed to 0.6 μM 2-HBA (bis(2-hydroxy-benzylidene)acetone), the specific activities of NQO1 and glutathione reductase increase by 6- and 1.5-fold, respectively. The total cellular glutathione content is also coordinately induced by 2.4-fold. In a more detailed study it is found that NQO1 is induced by 2-HBA in a concentration-dependent manner. Treatments with 2-HBA cause cell cycle arrest and apoptosis in both L1210 wild type cells and their Y8 drug-resistant counterparts in a concentration-dependent manner. 2-HBA can also activate caspase-3 and caspase-10. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.755 ml | 18.777 ml | 37.553 ml |
5 mM | 0.751 ml | 3.755 ml | 7.511 ml |
10 mM | 0.376 ml | 1.878 ml | 3.755 ml |
5 mM | 0.075 ml | 0.376 ml | 0.751 ml |
biological activity | 2-HBA is an effective NAD(P)H: quinone receptor oxidoreductase 1 (NQO1) inducer, can also activate caspase-3 (caspase-3) and caspase-10 (caspase-10). |
target | Caspase-3 Caspase-10 |
in vitro study | When L1210 cells are exposed to 0.6 μM 2-HBA (bis(2-hydroxy-benzylidene)acetone), the specific activities of NQO1 and glutathione reductase increase by 6- and 1.5-fold, respectively. The total cellular glutathione content is also coordinately induced by 2.4-fold. In a more detailed study it is found that NQO1 is induced by 2-HBA in a concentration-dependent manner. Treatments with 2-HBA cause cell cycle arrest and apoptosis in both L1210 wild type cells and their Y8 drug-resistant counterparts in a concentration-dependent manner. 2-HBA can also activate caspase-3 and caspase-10. |